Business Services Industry
NeuVis Announces Support for Enterprise JavaBeans and XML, Through BEA Systems, Inc's WebLogic 5.1 Application Server
Business Wire, April 18, 2000
Business/Technology Editors
SHELTON, Conn.--(BUSINESS WIRE)--April 18, 2000
NeuVis e-business platform will support leading B2B technology to
provide greater speed-to-market, flexibility and scalability
NeuVis, a leading builder of e-commerce exchanges and other e-business applications, today announced that its e-business platform supports Enterprise JavaBeans (EJB) and Extensible Markup Language (XML) through BEA's WebLogic 5.1 Application Server. This support underscores NeuVis' commitment to being technology neutral and providing its customers with greater flexibility and the latest technology.
WebLogic 5.1 Application Server is a leading J2EE platform offering e-commerce reliability, end-to-end security management and support of leading e-commerce technologies, such as XML and EJB. XML and EJB are two best of breed technologies for e-business environments. The technologies allow for a rapid development of e-business solutions.
"Our customers are in a hurdle race against their competitors. They demand flexibility in design and the latest technologies like XML and Java," said Arun Gupta, chairman of NeuVis. "The NeuVis e-business platform grows with our customers, and by supporting technologies like XML and Java, NeuVis gives them a real competitive edge."
Some of the main benefits of NeuVis' e-business platform's support of XML and EJB include a rapid rate of development of e-business exchanges and marketplaces. Because EJB focuses on an architected approach versus a timely hand-coding system, platforms can be designed faster. NeuVis' support of XML will allow for the NeuVis e-business platform to be highly flexible and scalable.
"Unlike other companies in this space, the NeuVis' e-business platform does not lock companies into one technology," said Gupta. "NeuVis' support of XML and EJB allows us to continue to reach our goals of providing our customers with one of the most technically advanced e-business systems in the industry. NeuVis offers its customers a reliable and secured e-business platform that effectively meets the demanding needs of this industry and protects against technology obsolescence."
About NeuVis
NeuVis, Inc., is a leading builder of B2B and enterprise-level e-business and e-commerce systems. The NeuVis e-business development platform works broadly across all technologies, providing rich vertical frameworks for buyers, sellers and marketplaces/exchanges. Their investors include: affiliates of Goldman Sachs (NYSE: GS), Lehman Brothers Venture Partners (NYSE: LEH), eFinanceworks, Galleon Group, GE Investment Corp., Allen and Company, Voyager Capital, The Chatterjee Group, J&W Seligman New Technologies Fund and Connecticut Innovations. The company is located in Shelton, Connecticut, and can be reached by phone at (203) 402-2000 or via the Internet at www.neuvis.com.
- 5 Rules for Immediate Annuities
- Death in the Family: 12 Things to Do Now
- Dumbest Things You Do With Your Money
- 6 Online Networking Mistakes to Avoid
- 401(k) Mistakes to Avoid
- 5 Economic Scenarios to Keep You Up at Night
- The Real ‘Best Places to Retire’
- Best Credit Cards for You
- 12 Tough Questions to Ask Your Parents
- The Real ‘Best Colleges’
- Home Buyer Tax Credit: How to Cash In
- Why You Shouldn't Bash Cash
- 8 Phony 'Bargains' and Better Alternatives
- Danger: 3 Debit Card Scams to Avoid
- 6 Myths About Gas Mileage
- 29 Fees We Hate Most
- Quick and Easy Ways to Boost Returns
- Best Stocks to Buy Now
- Lower Your Taxes: 10 Moves to Make Now
- New Jobs: 8 Lessons from Real-Life Career Switchers
- The New Job Market: Who Wins and Who Loses?
- Health Care Reform's Public Option: Everything You Need to Know
- Volunteer Work When Unemployed: Should You Work for Free?
- Whose Recovery Is This?
- Long-Term-Care Insurance: 4 Biggest Risks to Avoid
Most Recent Business Articles
- Psyadon Pharmaceuticals, Inc. Announces Regulatory Milestones and the Initiation of a Clinical Trial of Ecopipam in Lesch-Nyhan Disease
- Emergence of “Femtomedicine” - New Frontier of Biomed Sciences - Reported at First Global Congress on Nano Medicine
- Research and Markets: Ethiopia Power Market Outlook to 2020
- Research and Markets: Orphan Drugs in Asia-Pacific: from Designation to Pricing, Funding & Market Access
- Research and Markets: Now You See It - TV Program Sponsorship & Product Placement in China
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FHM Features Anna Benson, Baseball's Hottest Wife
- Building a DNA database: the federal government has just enacted two bills related to DNA. The first would drive the collection of DNA from all infants. The second would attempt to prevent the DNA that is collected from being misused
- America's most wanted j-o-b-s - 10 hottest employment opportunities
- Developmental sequence in small groups


